Clinical Trial Update: Evaluate the Neuroprotective Effect of Vitamin B6 and Vitamin B12 Against Vincristine Induced Neurotoxicity in Acute Lymphoblastic Leukaemia Patients [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/3 trial evaluated whether vitamin B6 and vitamin B12 can protect against vincristine-induced neurotoxicity in patients with acute lymphoblastic leukem…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Vincristine-induced Neurotoxicity

Drugs mentioned

• Vincristine (vincristine)
• Vitamin B6 and Vitamin B12 (pyridoxine and cobalamin)

Snippet

Sponsor: Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | Conditions: Vincristine Induced Neurotoxicity, Acute Lymphoblastic Leukaemia | Phase 2, Phase 3 | Status: COMPLETED